Relate
Rituxan |
| |
|
A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.
|
Cryoglobulinaemia is a medical condition in which the blood contains large amounts of cryoglobulins - proteins that become insoluble at reduced ...
|
Rituximab as related to Cryoglobulinemia
- Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Rituximab at 375 mg/m(2) x 4 is effective for refractory HCV-related mixed cryoglobulinemia. ... No sustained increase of HCV viremia after rituximab was observed. ...
- Acanthamoeba Encephalitis and Cryoglobulinemia | CDC EID
... year-old woman with therapy-refractory cryoglobulinemia treated with rituximab, ... and safety of rituximab in type II mixed cryoglobulinemia. Blood. ...
- Restoration of peripheral immune homeostasis after rituximab ...
... immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. ... Rituximab, an anti-CD20 monoclonal antibody, has been used to treat autoimmune ...
- Rapidly Fatal Acanthamoeba Encephalitis and Treatment of ...
tory cryoglobulinemia treated with rituximab, plasmaphere ... died of GAE after receiving rituximab. ... with cryoglobulinemia treated with rituximab. GAE is a ...
- Cryoglobulinemia -- Morra 2005 (1): 368 -- Hematology
... Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. ... in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia ...
- Blood -- Efficacy and safety of rituximab in type II mixed ...
Efficacy and safety of rituximab in type II mixed cryoglobulinemia ... 6. Coca P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinemia vasculitis. ...
- Blood -- Efficacy and safety of rituximab in type II mixed ...
Efficacy and safety of rituximab in type II mixed cryoglobulinemia ... The best treatment of type II mixed cryoglobulinemia (MC) has still to be defined. ...
- Cryoglobulinemia Home Page
Possible usefulness of Biaxin for Type I Cryoglobulinemia. Rituximab for HCV and other mixed cryoglobulinemias ... C virus (HCV) associated cryoglobulinemia. ...
- Anti-CD20 monoclonal antibody (rituximab) treatment for ...
... monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where ... Rituximab therapy for patients with mixed cryoglobulinemia vasculitis, ...
- Cryoglobulinemia
essential mixed cryoglobulinemia (40%), arthralgia or joint ... Rituximab is a drug currently used to treat non ... In the studies to date, rituximab has been ...
- Anti-CD20 monoclonal antibody (rituximab) treatment for ...
... that rituximab therapy for patients with mixed cryoglobulinemia vasculitis, HCV ... with the key words "cryoglobulinemia", "rituximab" and "anti-CD20" resulted in ...
- Treatment of essential mixed cryoglobulinemia
INTRODUCTION Essential mixed cryoglobulinemia, also called type II cryoglobulinemia, is most often induced by ... and safety of rituximab in type II ...
- Cryoglobulinemia
rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-3834. ... increase in the cryoglobulin level after rituximab therapy for ...
- Rituximab (Anti-CD20) for the Treatment of Hepatitis C ...
... Provided Keywords: Hepatitis Vasculitis Rituximab Cryoglobulinemia Recruitment ... Rituximab for ANCA-Associated Vasculitis (RAVE) Study ...
- Entrez PubMed
PubMed is the National Library of Medicine's search service that provides access to over ... Efficacy and safety of rituximab in type II mixed cryoglobulinemia. ...
- Unbound MEDLINE | Long-term efficacy of rituximab in ...
Unbound MEDLINE | Long-term efficacy of rituximab in hepatitis C virus-associated cryoglobulinemia. Journal article. Search by keyword, journal, author or by EBM ...
- Medline ® Abstract for Reference of 'Overview of ...
UpToDate, electronic clinical resource tool for physicians and patients that provides ... Efficacy and safety of rituximab in type II mixed cryoglobulinemia. AU ...
- A review of rituximab in cutaneous medicine
Rituximab is an effective treatment for mixed cryoglobulinemia. ... in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia ...
- Relationship Between Cryoglobulinemia-associated Nephritis ...
Abstract and Introduction: An algorithm based on the clinical severity of disease is proposed. Learn how rituximab might be a first-line option in severe cases.
- Nature Clinical Practice Nephrology | Drug Insight: rituximab ...
Nature Clinical Practice Nephrology will deliver timely interpretations of key research developments, translating the ... in type II mixed cryoglobulinemia. ...

Not Signed In -

